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Legionella pneumophila causes Legionnaires’ disease, a
severe form of pneumonia. L. pneumophila translocates more
than 300 effectors into host cells via its Dot/Icm (Defective in
organelle trafficking/Intracellularmultiplication) type IV secre-
tion system to enable its replication in target cells. Here, we
studied the effector LtpM, which is encoded in a recombination
hot spot in L. pneumophila Paris. We show that a C-terminal
phosphoinositol 3-phosphate (PI3P)-binding domain, also
found in otherwise unrelated effectors, targets LtpM to the
Legionella-containing vacuole and to early and late endosomes.
LtpM expression in yeast caused cytotoxicity. Sequence com-
parison and structural homology modeling of the N-terminal
domain of LtpM uncovered a remote similarity to the glycosyl-
transferase (GT) toxin PaTox from the bacteriumPhotorhabdus
asymbiotica; however, instead of the canonical DxD motif of
GT-A type glycosyltransferases, essential for enzyme activity
and divalent cation coordination, we found that a DxN motif is
present in LtpM. Using UDP-glucose as sugar donor, we show
that purified LtpM nevertheless exhibits glucohydrolase and
autoglucosylation activity in vitro and demonstrate that PI3P
binding activates LtpM’s glucosyltransferase activity toward
protein substrates. Substitution of the aspartate or the aspara-
gine in the DxNmotif abolished the activity of LtpM.Moreover,
whereas all glycosyltransferase toxins and effectors identified so
far depend on the presence of divalent cations, LtpM is active
in their absence. Proteins containing LtpM-like GT domains
are encoded in the genomes of other L. pneumophila isolates
and species, suggesting that LtpM is the first member of a
novel family of glycosyltransferase effectors employed to sub-
vert hosts.
Legionella pneumophila and related species are Gram-nega-
tive bacteria, which colonize a wide variety of ecological niches,
in particular aquatic environments (1). In these ecosystems, the
constant interaction with protozoa, unicellular phagocytes that
feed on bacteria, has driven the acquisition of virulence factors
by Legionella spp., enabling them to evade predation and
instead exploit the predators as replicative niches (2, 3). Respi-
ratory infection occurs through accidental inhalation of bacte-
ria-laden aerosols and can develop into a severe, potentially
fatal pneumonia, called Legionnaires’ disease (4). Legionella
spp. account for 3–5% of hospitalized cases of pneumonia and a
rising incidence of Legionnaires’ disease in many countries,
including the United States in recent years, highlighting Legio-
nella spp. as an emerging threat for human health (5, 6).
In L. pneumophila, an essential virulence factor for the sub-
version of phagocytes and pathogenesis is the Defective in
organelle trafficking/Intracellular multiplication (Dot/Icm)5
type IV secretion system (T4SS), which L. pneumophila uses
to translocate more than 300 effector proteins into a host
cell (7–9). The individual functions of most effectors remain
unknown; but it has become clear that effectors modulate
numerous processes, e.g. transcription, translation, ubiquitin-
signaling, and vesicle trafficking (10, 11). Most importantly, the
concerted action of effectors decouples the nascent Legionella-
containing phagosome from the phago-lysosomal degradation
pathway and remodels it into a unique organelle, the Legion-
ella-containing vacuole (LCV) (12). The staggering number of
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Dot/Icm T4SS effectors is believed to provide the bacteria with
the means to exploit a wide variety of diverse protozoan hosts
(13). In addition, the discovery of multiple layers of manipula-
tion of the small GTPase Rab1 through at least seven effectors
(SidM, SidD, AnkX, Lem3, LepB, LidA, and PieE), resulting in
tight spatio-temporal control of its activity, illustrates that the
large effector arsenal also serves to fine-tune host cell processes
(14, 15).
The effector repertoire expands by gene duplication giving
rise to families of paralogue effectors, horizontal gene transfer
between bacteria, and most likely, gene acquisition from
eukaryotic hosts (16–19). Moreover, the detailed functional
characterization of effectors, such as SidM (20–23), RavZ (24,
25), and SetA (26), revealed that many effectors are modular
and consist of variable combinations of several functional
domains. Deciphering the biochemical functions of these dif-
ferent effectors, including their numerous functional domains,
is not only key to uncover how Legionella spp. subvert the host
but also how the virulence factor reservoirs of these emerging
human pathogens evolve.
Recombination hot spots in L. pneumophila genomes might
play an important role in the biogenesis of new effectors (27).
Among the proteins encoded in one of these hot spots is
Lpp0356 (27), which we identified previously as putative Dot/
Icm T4SS effector based on the presence of a C-terminal
domain, which shares 64% identity with the phosphoinositide
3-phosphate (PI3P)-binding domain of the effector LtpD
(Lpw_03701, WP_038837285.1) (28). Here, we characterized
Lpp0356 in detail. We demonstrate that Lpp0356 is translo-
cated by theDot/IcmT4SS, andwe therefore designate it Legio-
nella translocated proteinM (LtpM).We found that the N-ter-
minal domain is a new type of glucosyltransferase, which does
not rely on a catalytic DxD motif and metal ion co-factors like
classical type A glycosyltransferases (GT-As), such as Lgt1 (29)
and SetA (26). Moreover, we also found that the enzymatic
activity ismodulated by phospholipid binding through an inter-
play between the GT- and PI3P-binding domains.
Results
LtpM is a newDot/Icm T4SS translocated effector, which
localizes to the LCV
Toprove that LtpM is aDot/IcmT4SS effector, we employed
the -lactamase (TEM1) translocation assay (30), which mea-
sures the change of fluorescence emission of a-lactam Fo¨rster
resonance energy transfer (FRET) reporter (CCF2-AM) upon
cleavage by TEM1–effector fusion proteins that are delivered
into the host cell cytoplasm. Infection of Raw264.7 macrophage–
like cells with L. pneumophila Paris WT expressing TEM1–
LtpM or -LtpD, but not the corresponding T4SS-deficient
dotA strains orWT bacteria expressing a TEM1 fusion to the
housekeeping protein Fab1, resulted in a sharp increase of the
ratio of the fluorescence signals of the cleaved -lactam prod-
uct over the substrate (Fig. 1A), showing that LtpM is translo-
cated into host cells by the Dot/Icm T4SS.
To determine the localization of LtpM in infected host cells,
we infected human lung epithelial A549 cells (Fig. 1B) or mac-
rophage-likeTHP-1 orRaw264.7 cells (Fig. S1)withL. pneumo-
phila Paris WT expressing LtpM fused to four hemagglutinin
tags (4HA–LtpM), immunostained and analyzed the samples by
immunofluorescence (IF) microscopy. 6 h post-infection, 4HA–
LtpMwasdetected surrounding theWTbacteria inapattern rem-
iniscent of LCV-associated effectors such as SidM (15). These
findings show that LtpM is translocated by theDot/IcmT4SS and
indicate that it localizes to the cytoplasmic leaflet of LCVs.
LtpM is dispensable for replication of L. pneumophila in host
cells
LtpM is found in L. pneumophila Paris and 48 other L. pneu-
mophila strains (Table S1) and is highly conserved (98% iden-
Figure 1. LtpM is aDot/IcmT4SS translocatedeffector,which localizes to
the LCV.A,-lactamase (TEM1) translocation assays. L. pneumophilaParisWT
(black bars) or T4S-deficient dotA mutant (white bars) expressing TEM1-
fused to LtpM were used to infect Raw264.7 macrophages (m.o.i. 40) for 1 h
before addition of the cell-permeable CCF2-AM FRET TEM1 substrate. Bacte-
ria expressingTEM1 fused to LtpDor thehousekeepingprotein FabI servedas
positive and negative controls, respectively. 3 h post-infection, fluorescence
emissionsof intact andTEM1-cleavedCCF2-AMsubstratewere recordedwith
a Fluostar Optima plate reader (410-nm (10-nm bandpass) excitation and
450- and 520-nm emission filters) and the emission (E) ratio as indicator for
translocation rate calculated for each sample. Error bars represent standard
deviations (S.D.). Results are representative of three independent experi-
ments. B, IFmicrographs of A549 lung epithelia cells infectedwith L. pneumo-
phila Paris WT expressing GFP and LtpM-fused to four HA tags. 6 h post-
infection, cells were fixed with PFA and then processed for IF microscopy
using anti-HAantibody (red). DNAwas visualizedwithDAPI (cyan). A regionof
interest (ROI) of the imaged cell was enlarged to show the LCV-like pattern of
LtpM around the bacteria. Data are representative of at least three indepen-
dent experiments. Scale bar, 2 m.
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tity); however, it is not present in all sequenced strains, suggest-
ing that it is not a core but an accessory effector and/ormight be
recently acquired. Notably, proteins showing partial homology
to either the C-terminal putative PI3P-binding domain or the
N-terminal domain of LtpM are found in hundreds of L. pneu-
mophila isolates but also other Legionella spp. and few other
-proteobacteria (Table S1), indicating that these domains
might be common building blocks for effectors.
To determine the contribution of LtpM to intracellular sur-
vival and replication of L. pneumophila Paris, we generated a
ltpM deletion mutant and challenged THP-1 cells or the pro-
tozoan model Dictyostelium discoideum with WT or ltpM
mutant bacteria expressing fluorescent proteins. Continuous
measurement of the increase in fluorescence revealed that
L. pneumophilaltpMwas not attenuated in its ability to infect
and replicate in the two hosts (Fig. S2), showing that LtpM is
not essential for virulence.
LtpM(469–639) binds PI3P with high affinity and targets LtpM
to PI3P-containingmembranes
LtpM exhibits homology of its C terminus to the PI3P-bind-
ing domain of LtpD (28). To assess whether LtpM binds PIPs,
we purifiedHis6-tagged LtpMvariants and performed protein–
lipid overlay assays (26, 28, 31). This revealed strong binding of
full-length LtpM and LtpM(469–639) to PI3P with high spec-
ificity, whereas LtpM(1–460) lacking the putative PI3P-bind-
ing domain showed no specific binding to any of the phosphoi-
nositides (Fig. 2A; Fig. S3). To quantify the affinity of LtpM for
PI3P, the biotin-conjugated lipid was immobilized on strepta-
vidin-coated sensor chips, and the binding of purified LtpM
was recorded by surface plasmon resonance spectroscopy. The
analysis (Fig. 2B) showed dose-dependent binding of LtpM to
the lipid anchor and allowed us to determine an equilibrium
binding dissociation constant Kd of 591  203 nM (Fig. 2C),
which is in the same range as the PI3P-binding affinity of the
effector SetA (809 51 nM (26)).
We next used a panel of GFP-tagged biosensors for different
PIPs and confocalmicroscopy to analyze whether in transiently
transfectedHeLa cells LtpMwas directed tomembranes rich in
a specific phosphoinositide phosphate (Fig. 2D). Ectopically-
expressed mCherry–LtpM co-localized with GFP biosensors
for PI3P (p40Phox PX domain of NADPHoxidase) and PI(3,5)P2
(cytoplasmic domain ML1N of the receptor mucolipin 1) in
vesicles throughout the cell, but not with sensors for PI4P (PH
domain of oxysterol-binding protein 1 (OSBP)), PI(3,4)P2, and
PI(3,4,5)P3 (PH domain of AKT) or PI(4,5)P2 (PH domain of
PLC1). LtpM(1–462) showed diffuse cytoplasmic and nuclear
localization, whereas LtpM(456–639) co-localized with a PI3P
sensor as the full-length protein (Fig. S4). These data show that
the last 170 amino acid residues of LtpM compose a high-affin-
ity PI3P-binding domain, which is essential and sufficient to
target LtpM to PI3P-containing membranes.
LtpM shows remote similarity to glycosyltransferase toxins
Next, we performed a bioinformatics analysis of LtpM(1–
460) to uncover conserved sequence motifs, revealing the pres-
ence of three putative ankyrin repeats preceding the PI3P-bind-
ing domain (LtpM(329–435)). Ankyrin repeats are typically
eukaryotic domains involved in protein–protein interactions,
but are also frequently found in Legionella effectors (32).More-
over, sequence and structural homology searches using NCBI
BlastP and Phyre2 indicated a remote similarity of LtpM(9–
145) to the glycosyltransferase (GT) domain of the insecticidal
protein toxin PaTox of the entomopathogen Photorhabdus
asymbiotica (33) and to the Legionella glycosyltransferase
effector SetA (26, 34). Alignment of LtpMwith theGTdomains
of selected well-characterized GTs and modeling of LtpM(9–
145) on the crystal structure of PaTox-G from P. asymbiotica
(Fig. 3, Fig. S5, A and B, File S1) (33) revealed that conserved
amino acid residues of LtpM are positioned around the cata-
lytic pocket of PaTox. Among the conserved residues are aspar-
tic acid 124 and tryptophan 13, which correspond to residues of
PaTox implicated in stabilizing the interaction with the UDP-
sugar donor. Remarkably, a characteristic DxD motif, which
plays a critical role in catalysis in PaTox (33) and other mem-
bers of the GT-A family of glycosyltransferases (35), is not con-
served in LtpM. This DxD motif interacts with the hydroxyl
groups of the UDP-sugar and coordinates an essential divalent
metal ion cofactor, e.g. Mg2 or Mn2. In LtpM, the second
aspartate is replaced by an asparagine (Asn-142).
LtpM has glucohydrolase and auto-glucosyltransferase
activity
The results of the bioinformatics analysis prompted us to
determine whether LtpMpossesses glucohydrolase and/or glu-
cosyltransferase activity. All glycosyltransferase toxins identi-
fied so far, including PaTox and the previously characterized
Legionella GT effectors SetA and Lgt1–3, use the nucleotide
sugar donors UDP-GlcNAc (UDP-GlcNAc) or UDP-glucose
(UDP-Glc) to glycosylate protein targets (36). In the absence of
protein targetsmostGTs hydrolyzeUDP-sugar donors (35, 37).
To test whether LtpM displays glycohydrolase activity, recom-
binant His6-tagged LtpM was incubated with radiolabeled
UDP-14C-sugars, and the release of 14C-sugars was mea-
sured by autoradiography of thin layer chromatograms
(TLCs) of the reactionmixtures. These experiments revealed
that LtpM causes hydrolysis of UDP-[14C]glucose but not of
UDP-[14C]GlcNAc (Fig. 4A).
Hydrolysis of UDP-[14C]glucose by SetA was previously
found to be accompanied by auto-glucosylation (26). Also,
LtpM catalyzed an auto-glucosylation reaction in the presence
of UDP-[14C]glucose but not with UDP-[14C]GlcNAc (Fig. 4B).
To further assess the sugar donor specificity of LtpM, the
ability of a panel of unlabeled nucleotide sugars to outcompete
UDP-[14C]glucose was analyzed (Fig. 4C). Addition of a 100-
fold excess of UDP-glucose nearly completely abolished the
release of [14C]glucose by LtpM. Also, UDP caused an inhibi-
tion of the reaction, whereas other sugar donors exerted no
effect or only moderate effects on hydrolysis, suggesting that
UDP-glucose is the preferred sugar substrate for LtpM.
We next investigated the role of the PI3P-binding domain
and the ankyrin repeats for the glucohydrolase activity of LtpM
(Fig. 4, D and E). This showed that LtpM(1–460), lacking the
PI3P-binding domain, retained full activity. Shorter LtpM frag-
ments were expressed but showed some signs of instability (Fig.
S5C) and completely lost the glucohydrolase activity, suggest-
L. pneumophila glycosyltransferase LtpM
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ing that the ankyrin repeat region is important for the function
and stability of the enzyme.
PI3P increases the glucosyltransferase activity of LtpM
We next asked whether LtpM can glucosylate artificial sub-
strates and whether this is influenced by phosphoinositide
binding. LtpM modified the artificial substrate BSA, and the
rate of the glucosylation was increased up to 5-fold in the pres-
ence of PI3P (Fig. 5A). At the same time, the glucohydrolase
activity was not affected by addition of PI3P or PI4P (Fig. 5B).
The autoglucosylation of the enzyme was decreased by the
addition of PI3P (Fig. 5C). The concentration–effect curves of
influence of PI3P and PI4P on the glucosyltransferase activity of
LtpM with BSA as substrate revealed a higher potency of PI3P
as compared with PI4P. At high concentrations, PI4P reached
the same level of activation as PI3P (Fig. 5D). These data show
that phosphoinositide binding enhances the transfer of the sug-
ar-moiety by LtpM onto target proteins.
Figure 2. C-terminal domain of LtpM specifically binds PI3P and targets LtpM to PI3P-containing membranes. A, protein–phospholipid overlay assay
with LtpM protein fragments, LtpM(1–460) and LtpM(469–639) (each 100 nM). Nitrocellulose membranes pre-spotted with 100 pmol of phospholipids were
incubated with the indicated proteins and probed with an anti-LtpM serum. Left lanes, lysophosphatidic acid (LPA), lysophosphocholine (LPC), phosphatidy-
linositol (PI), phosphatidylinositol phosphate (PIP), phosphatidylethanolamine (PE), phosphatidylcholine (PC). Right lanes, sphingosine 1-phosphate (S1P),
phosphatidylinositol phosphate (PIP), phosphatidic acid (PA), phosphatidylserine (PS).B,blank subtracted sensorgrams showingbindingof LtpMtobiotin-PI3P
immobilized on an SA-Chip measured by surface plasmon resonance spectroscopy. LtpM was diluted in a 2-fold consecutive dilution series ranging from 5.7
M to 11 nM and flowed over the chip surface for 110 s with subsequent washing steps of 500 s. C, equilibrium binding analysis indicates a Kd 591 203 nM
(S.D., n 3). B and C, results are representative of three independent experiments.D, co-localization of LtpMwith sensor domains for cellular phosphoinositi-
des. LtpM co-localizes with PI3P and PI(3,5)P2-containing vesicles but not with the intracellular membranes containing PI4P, PI(4,5)P2, PI(3,4)P2, or PI(3,4,5)P3.
HeLa cells were transiently transfected with pmCherry–LtpM (center, red) and analyzed for co-localization with specific probes for cellular phosphoinositides
(left, green, pEGFP): the p40Phox PX domain of NADPH oxidase is specific for PI3P; the cytoplasmic domain ML1N of the receptor mucolipin-1 is specific for
PI(3,5)P2; the PHdomain of OSBP is specific for PI4P localizing at theGolgi/trans-Golgi network; the PHdomain of AKT recognizes both PI(3,4)P2 and PI(3,4,5)P3;
and the PH domain of PLC1 is specific for PI(4,5)P2. After 18 h, cells were fixed and analyzed with a confocal microscope. Co-localization is depicted in yellow
(right panel). Insets show amagnification of the regions marked withwhite lines. Scale bar, 10 m.
L. pneumophila glycosyltransferase LtpM
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LtpM possesses glucohydrolase and glucosyltransferase
activity in the absence of cations
The hallmark of typeAGTs is the presence of theDxDmotif,
which coordinates a divalent metal cation and UDP-glucose.
The degeneration of the DxD to a DxNmotif in LtpM (Fig. 3) is
unique as compared with all other glycosyltransferase toxins.
To clarify the role of the DxNmotif of LtpM, we generated the
D140N mutant, resulting in an NxN motif, which is known to
inhibit the enzyme activity of many toxin glycosyltransferases
(36). LtpM NxN exhibited no glucohydrolase and glucotrans-
ferase activity. Furthermore, we changed asparagine 142 to
aspartate to restore the classical DxDmotif. Also, this substitu-
tion rendered the enzyme inactive in glucohydrolase and auto-
glucosylation autoradiography assays (Fig. 6, A and B), indicat-
ing that each residue of theDxNmotif is critical for the function
of the active site of LtpM.
The lack of the classical DxD motif does not exclude that
LtpM still relies on a divalent metal ion cofactor for catalysis.
Figure 3. LtpM shows sequence similarity to bacterial glycosyltransferase toxins. Sequence alignment of bacterial GT-A GTs (Lgt1, Lgt2, and Lgt3 from
L. pneumophila, TcdA and TcdB from C. difficile, SetA from L. pneumophila, and PaTox from P. asymbiotica) and the LtpM-like putative glycosyltransferases
(LtpM-like GTs) from Legionella spp. (LtpM from L. pneumophila; Lbru_2087 from L. brunensis; Lnau_0778 from L. nautarum; Llan_2410 from L. lansingensis;
Ldro_1318 from L. drozanskii; Lisr_1509 from L. israelensis; Lfa_0737 from L. fallonii; andLche_3126 from L. cherrii). Aminoacids strongly conservedamongboth
groups are shown in red. Amino acids conserved only inside one of the group are shown in green. Variable amino acids are shown in yellow.
Figure4. LtpMspecificallyhydrolyzesUDP-Glc in vitroandautoglucosylates.A, time courseof aUDP-sugar hydrolase activity using LtpM (1M) in abuffer
containing 50 mM Hepes (pH 7.5), 150 mM KCl, 1 mM MnCl2, 2 mM MgCl2 at 30 °C. The reaction components were separated by PEI-TLC, and products were
detectedby autoradiography.B, autoglucosylationof LtpM. LtpMglucosylates itselfwithUDP-[14C]Glc but notwithUDP-[14C]GlcNAc. Reactionwasperformed
as in A, and products were separated in SDS-PAGE and detected by autoradiography. An autoradiogram (top panel) and a Coomassie-stained SDS-PAGE
(bottom panel) are shown. C, determination of the donor substrate specificity. Hydrolysis of UDP-[14C]Glc by LtpM in presence of 100-fold excess of cold
nucleotide sugars. UDP-Glc andUDP inhibit hydrolysis of UDP-[14C]Glc.B andC, error bars represent S.D. of three technical replicates. Results are representative
of three independent experiments. D, schematic representation of the truncated LtpM variants used in this study. E, time course of UDP-glucose hydrolase
activity of LtpM truncations. Hydrolysis of UDP-[14C]glucose (10 M) was performed with LtpMFL, LtpM(1–460), LtpM(1–365), or LtpM(1–340) (each 1 M) at
30 °C in a buffer containing 50mMHepes (pH 7.5), 10mMDTT, 2 mMMgCl2 and 1mMMnCl2. At the indicated time points, the products were separated by TLC
and analyzed autoradiographically. Error bars represent standard deviations of three independent experiments.
L. pneumophila glycosyltransferase LtpM
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To probe this, glucohydrolase and glucosyltransferase assays
were carried out in the absence of added cations, in the pres-
ence of the chelator EDTA, or with added Mg2, Mn2, Ca2,
or Zn2. As a control, we used SetA, which strictly depends on
Mn2 or Mg2. In the presence of 100 M EDTA, the glucohy-
drolase activity of SetA was completely inhibited, whereas
LtpM exhibited robust activity (Fig. 6C). Addition of increasing
amounts of MnCl2, MgCl2, CaCl2, or ZnCl2 up to equimolar
concentration with EDTA had a minimal enhancing effect on
the activity of LtpM (Fig. S6, A–D). Over the same concentra-
tion range, the activity of SetA strongly increased to match and
even surpass LtpM in the presence of equimolar MnCl2 or
MgCl2 (Fig. S6, A–D). A further increase in the concentrations
of any of the four metal ions further enhanced the glucohydro-
lase activity of SetA. Excess ofMgCl2,MnCl2, andCaCl2 also led
to a moderate increase of the activity LtpM; but further addi-
tion of ZnCl2 reduced its activity (Fig. 6C and Fig. S6, A–D).
We next studied the metal dependence of the glucosyltrans-
ferase activity with the artificial substrate BSA (Fig. 6D; Fig. S7).
The glucosyltransferase activity of SetA was completely depen-
dent on divalent cations and only observed when at least
equimolar or excess amounts of themetal ions over EDTAwere
present (Fig. S7). In contrast, LtpM exhibited glucosyltrans-
ferase activity in the presence of 1 mM EDTA without added
divalent cations. This robust glucosylation of BSA by LtpMwas
further increased when the concentrations of MgCl2, MnCl2,
and CaCl2 exceeded that of EDTA but was inhibited by ZnCl2.
We also tested the effects of the monovalent cations K and
Na. The activity of the GT domain of Clostridium difficile
toxin B (TcdB) is known to strongly increase by addition of K.
LtpM was not affected by the presence or absence of monova-
lent ions (Fig. 6E). Taken together, LtpMdiffers fromSetA in its
divalent cation dependence and represents a new type of GT
that possesses enzyme activity in the absence of divalent metal
ions.
To gain further insights into the catalytic mechanism of
LtpM, we mutated conserved amino acid residues, which were
implicated in sugar-donor binding and catalysis in other type A
GTs, and we determined the glucohydrolase activity of the
mutants. Change of tryptophan 13 to alanine or aspartate 124
into asparagine resulted in complete loss of enzyme activity
(Fig. 6F), demonstrating their catalytic or structural impor-
tance. This loss of activity was not due to the loss of protein
stability as demonstrated by SDS-PAGE analysis. Moreover,
various highly conserved amino acids found in classical toxin
glycosyltransferases are changed in LtpM and related glycosyl-
transferases (Fig. 3), e.g. lysine 123 and serine 127 of LtpM sub-
stitute otherwise conserved serine and arginine residues. We
Figure 5. PI3P activates theglucosyltransferase activity of LtpM.A, time course of glucosylation of BSAwith orwithout 1MPI3P. BSAwas used as artificial
glycosyl-acceptor substrate of LtpM. BSA was incubated with LtpM (25 nM) in presence of 10 M UDP-[14C]glucose with or without 1 M PI3P in a buffer
containing 50 mM Hepes, 1 mM MnCl2, 2 mM MgCl2 at 30 °C for the indicated time. The modified proteins were separated by SDS-PAGE, dried, and detected
radiographically. Individual measurements were normalized to the value recorded for the BSA glucosylation after a 60-min reaction without PI3P. B, UDP-
glucohydrolase activity of LtpM is independent of PI3P binding. Time course of UDP-[14C]Glc hydrolysis by LtpM in presence of 10MPI3P (open circles) or PI4P
(black triangles) or without any PIPs (control, black circles). UDP-[14C]Glc (10 M) was incubated with LtpM (200 nM) in a buffer containing 50 mM Hepes, 1 mM
MnCl2, 2 mM MgCl2, and 10 mM DTT at 30 °C. The reaction components were separated by TLC, and products were detected by autoradiography. C, autoglu-
cosylation of LtpM is inhibited by PI3P. Time course of LtpM autoglucosylation with or without 10 M PI3P. LtpM (each 4 M) was incubated with UDP-
[14C]glucose (10M) in a buffer containing 50mM Hepes, 1 mMMnCl2, 2 mMMgCl2, and 10mMDTT at 30 °C. Individual measurements were normalized to the
value recorded for LtpM autoglucosylation after a 60-min reactionwith PI3P.NS, not significant; *, p 0.05.D, activation of GT activity of LtpM in the presence
of increasing concentrations of PI3P or PI4P. Reactions were performed as in B. Individual measurements were normalized to the value recorded for the BSA
glucosylation without any PIP added. A–D, data represent the mean of three independent experiments. Error bars represent standard deviations. RU, relative
units; V, velocity.
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generated LtpM K123S and S127R mutants and analyzed their
glycohydrolase activity. Bothmutants were unable to hydrolyze
UDP-glucose indicating a crucial role of lysine 123 and serine
127 in the catalytic activity of LtpM. Taken together, the data
show that the active site of LtpM is made up of a new combina-
tion of amino acid residues, enablingmetal-independent gluco-
syltransferase activity.
Ectopic expression of LtpM impacts viability of eukaryotic cells
After establishing the GT activity of LtpM, we set out to
elucidate its function. As we did not observe any impact of
the chromosomal deletion of ltpM on intracellular growth of
L. pneumophila (Fig. S2), we focused our effort on LtpM
expression assays. The Legionella GT effectors Lgt1 and SetA
were shown to be cytotoxic when expressed or delivered into
eukaryotic cells (26, 38). To study the cytotoxicity of LtpM, we
used an inducible system to express LtpM, LtpMNxN, or LtpM
DxD mutants in the budding yeast Saccharomyces cerevisiae.
Plating of serial dilutions of the yeast showed that induction of
WT LtpM but not of the LtpM NxN mutant inhibited growth
(Fig. 7A). The DxD mutant showed a very slight inhibitory
effect on growth. The effects were not due to reduced expres-
Figure 6. LtpM is a metal ion-independent glucosyltransferase. A, LtpM WT, but not the DxD and NxN mutants, hydrolyzes UDP-glucose in vitro. Time
course of UDP-glucose hydrolysis using LtpM, LtpMNxN or LtpM, DxDmutants (1M each) is shown. Reactionswere performed for the indicated time at 30 °C
in a buffer containing 10M UDP-[14C]Glc, 50mM Hepes (pH 7.5), 10mMDTT, 2 mMMgCl2, and 1mMMnCl2. The reaction components were separated by TLC,
andproductsweredetectedby autoradiography.B, autoglucosylationof LtpM. TheWTenzyme, but notNxNandDxDmutants of LtpM, glucosylates itselfwith
UDP-[14C]Glc. Reactions were performed as in A, and products were separated in SDS-PAGE and detected by autoradiography. An autoradiogram (top panel)
and a Coomassie-stained gel (bottom panel) are shown. C, UDP-glucose hydrolase activity of LtpM or SetA (1 M each) in the presence of EDTA (100 M) with
orwithout additionof anexcess (1mM)ofMnCl2,MgCl2, CaCl2, or ZnCl2. Reactionswereperformedat 30 °C for 30min in abuffer containing10MUDP-[
14C]Glc,
50mMHepes (pH 7.5), 10mMDTT.D, glucosylation of BSA (2.5g) by LtpM or SetA (25 nM each) in the presence of EDTA (1mM) with or without addition of an
excess (3 mM) of the indicated divalent ions (MnCl2, MgCl2, CaCl2, or ZnCl2). Reactions were performed at 30 °C for 40 min in a buffer containing 1 M PI3P, 10
M UDP-[14C]Glc, 50 mM Hepes (pH 7.5), 10 mM DTT. E, hydrolysis of UDP-glucose by LtpM and GT domain of TcdB in the presence of Na or K. TcdB, but not
LtpM, needs K andMg2 for activation. Reactions were performed at 30 °C in a buffer containing 50mMHepes (pH 7.5), 1 mM EDTA, 10mMDTT, 3mMMgCl2,
100 mM NaCl, or KCl. Individual measurements were normalized to the value recorded for the reaction in the presence of 100 mM KCl. F, top, hydrolysis of
UDP-glucose by WT His-tagged LtpM (WT) or its mutant variants W13A, K123S, D124N, or S127R. Reactions were performed as in A for 30 min. Bottom,
Coomassie-stainedgel loadedwith 5gof the correspondingproteins used in the reactions.A, B, and F, error bars indicate standarddeviations of two technical
replicates. Data are representative of three independent experiments. C–E, error bars indicate standard deviations of three independent experiments.
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sion of the LtpM mutants as Western blottings revealed equal
or even higher protein levels. Consistent with the glucohydro-
lase assays (Fig. 4E), expression of LtpM fragments in the yeast
(Fig. S8) demonstrated that LtpM(1–460) was the minimal
domain required for the growth inhibition.
Next, we assessed the effect of ectopic expression of
mCherry-tagged LtpM or inactive LtpM-NxN on cell viability
using time-lapse microscopy. This did not reveal any immedi-
ate cytotoxicity or differences between the two LtpM variants
within the first 2 days post-transfection of HeLa cells; however,
60 h post-transfection significantly (p 0.026) less viable cells
were observed in the pmCherry–LtpM-transfected sample
compared with the pmCherry–LtpMNxN or pmCherry-trans-
fected controls (Fig. 7B). The data show that LtpM uses its GT
domain to target cellular processes, which are important for cell
viability/growth in yeast and mammalian cells.
LtpM blocks themicrotubule-dependentmovement of
endosomes
Lgt1 causes toxicity by inhibiting translation; however, LtpM
did not show a similar effect in in vitro translation assays (Fig.
S9). As LtpM localizes to PI3P-containing vesicles, we hypoth-
esized that it might exert its effect on the cell by modulating
targets in these compartments (Fig. 2D). To delineate the
nature of the LtpM-containing vesicles, we performed co-
transfections of pmCherry–LtpM with plasmids encoding GFP-
tagged Rab GTPases as markers of different membranes. Con-
focal immunofluorescence microscopy showed that mCherry–
LtpM and -LtpM NxN co-localized with the early and late
endosomal GTPases Rab5 and Rab7 but not with Rab6 and
Rab11 (Fig. 8A), which characterize recycling endosomes that
mediate recycling of endocytosed cargo back to the cell surface.
We next determined whether LtpM interfered with different
membrane trafficking pathways, in which early and late endo-
somes participate. Ectopic expression of mCherry–LtpM nei-
ther affected the retrograde transport of cholera toxin from the
cell surface via endosomes to the Golgi apparatus (Fig. S10, A
andB) nor caused a significant defect in the recycling of the iron
carrier transferrin from endosomes to the cell surface (Fig.
S10C).
Furthermore, we visualized the movement of the vesicles
loaded with mCherry–LtpM or -LtpM NxN in HeLa cells. We
recorded time-lapse movies of the living cells and analyzed
tracks of the vesicles (Fig. S11A and Movies S1–S4). LtpM-
labeled vesicles moved with the mean velocity of 0.10  0.03
m/s (n 9) for theWT LtpM and 0.16 0.04 m/s (n 15)
for the inactive mutant showing that significantly less vesicle
movement is present in LtpM-expressing cells compared with
the NxN mutant (Fig. 8B). Co-expression of mCherry–LtpM
and enhanced GFP-tubulin indicated that LtpM-labeled vesi-
cles moved bidirectionally along microtubules (Fig. S11B). To
validate this, we used the microtubule-depolymerizing drug
nocodazole, as a control. Only diffuse undirected vesicle move-
ment with the mean velocity of 0.07  0.01 m/s (n  7) was
observed in nocodazole-treated cells (Movies S5 and S6).
pmCherry–LtpM and -LtpM NxN were expressed at the same
level in the transfected HeLa cells indicating that the inhibitory
effect of LtpM resulted from the glucosyltransferase activity of
the effector and not from the higher expression of the WT
compared with the inactive mutant (Fig. S11C).
Discussion
L. pneumophila produces hundreds of Dot/Icm T4SS effec-
tors to ensure its survival and replication within the LCV in
phagocytic host cells. Less than 10% of the identified effectors
have been studied in detail. Here, we characterized the L. pneu-
mophila effector LtpM, which, based on similarity to the effec-
tor LtpD, was predicted to be a new modular Dot/Icm T4SS
effector (28). We verified that LtpM is translocated by the Dot/
Icm T4SS into target cells and demonstrated that the C-termi-
nal domain of LtpM (amino acids 469–639), which shares 64%
sequence identity with LtpD (amino acids 472–679) (28), selec-
tively binds PI3P with an affinity of 591 nM and directs LtpM to
membranes. Moreover, co-expression studies revealed co-lo-
Figure 7. Toxicity in mammalian cells and yeast. A, spot-test assay of
growth phenotypes of S. cerevisiae. LtpM inhibits growth of yeast. Exchange
of the DxN motif to NxN leads to the loss of toxicity. A DxD mutant demon-
strates lower toxicity compared with the WT. Yeast were transformed with
pESC-His () or pESC-His-basedplasmids coding forWTLtpM (DxN) andLtpM
mutants: D140N (NxN) and N142D. Western blotting demonstrates produc-
tion of c-Myc–tagged LtpM and LtpM mutants induced by galactose in
S. cerevisiae strains. Antibodies against a ribosomal protein Rps9were used as
an input control of the lysates. B, LtpM represses growth of HeLa cells. The
number of attached HeLa cells expressing LtpM WT (magenta) is reduced
comparedwith the cells expressing LtpMNxN (cyan) or fluorescence reporter
alone (blue). Graph showing count of attached transfected cells per image
over the indicated time. HeLa cells were transiently transfected with
pmCherry–LtpM, pmCherry–LtpMNxN, or pmCherry (reporter control). Time-
lapse movies of the transfected cells were started 18 h post-transfection and
were recorded for another 42 h using similar fields of view. The number of
attached transfected cells per image were counted, and values were normal-
ized to the values referred to the time point 18 h (start of the observation).
Values for the individual datapoints, themeanvalues, and standarddeviation
(S.D.) ofn8biological replicates are shown.Data are representativeof three
independent experiments. *, p 0.05.
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calization of LtpM with well-characterized biosensors for PI3P
(p40Phox) and PI(3,5)P2 (MLIN1), whereas co-localization with
biosensors for PI4P, PI(3,4)P2, and PI(3,4,5)P3 or PI(4,5)P2 was
not observed.
The use of PIP-binding domains for membrane anchoring
and subcellular targeting has been established as common
strategy for an increasing number of L. pneumophila effector
proteins (39). PI4P-binding domains of DrrA/SidM (40) and
SidC (41) and the PI3P-binding domain of RavZ (24) were
structurally and functionally characterized in detail. Notably,
structural homology modeling did not match the lipid-binding
domain of LtpM to any of these bacterial or other eukaryotic
PIP-binding domains or showed striking sequence similarities
to the PI3P-binding domains of the effectors LidA (21), LpnE
(42), RidL (43), and SetA (26). This indicates that the PI3P-
binding domains of LtpM and LtpD, which are also found in
dozens of other proteins across Legionella isolates, belong to a
new family, which has been acquired or evolved independently
from previously described domains.
In all previously characterized effectors, the PIP-binding
domains are variably combinedwith one ormore domains with
diverse functions, for example proteases (24) or ubiquitin
ligases (41), that manipulate host targets. The N-terminal
domain of LtpM does not bear high homology to LtpD or con-
served domains recognized by the PFAM database (44); how-
ever, we here discovered that it shares similarity to glycosyl-
transferase toxins, including the L. pneumophila effectors SetA
(26) and Lgt1–3 (38, 45), P. asymbiotica toxin PaTox (33), and
Figure 8. LtpMmodulates endosomal vesicle trafficking in HeLa cells. A,HeLa cells were transiently transfectedwith pmCherry–LtpM or pmCherry–LtpM
NxN (center, red) and analyzed for co-localization with specific marker proteins for vesicular compartments (left, green): pEGFP-Rab5; pEGFP-Rab7A; pEGFP-
Rab6; and pEGFP-Rab11. After 18 h, cells were fixed and analyzed with a confocal microscope. Images are representative of at least three independent
experiments. Co-localization is depicted in yellow (right panel). Insets show amagnification of the regionsmarkedwithwhite lines. Scale bar, 10m. B, velocity
of LtpM-labeled vesicleswas analyzed inHeLa cells. HeLa cellswere transfectedwith pmCherry–LtpMWTor -LtpMNxN for 18 h. Nocodazole-treated cellswere
used as a control. Nocodazole (10M) was applied for 2 h before microscopy. Single cell microscopy time-lapse movies (3 min, 1 frame/s) were recorded, and
the velocity of LtpM-labeled vesicles was analyzed (ImageJ Software). The mean velocity of the vesicles labeled with WT LtpM is significantly lower than the
mean velocity of the vesicles labeled with the enzymatically inactive NxN mutant. For the quantification of the experiment, at least 1000 tracks per cell were
analyzed. Error bars indicate standard deviations of at least seven biological replicates. ****, p 0.0001.
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the family of large clostridial glucosylating toxins (e.g. C. diffi-
cile toxins TcdA and TcdB) (46).
We demonstrated that LtpMpossesses glucohydrolase activ-
ity and prefers UDP-glucose as a substrate, which results in
auto-glucosylation but also modification of artificial substrates
such as BSA in vitro. Remarkably, we show that addition of PI3P
increased the glucosyltransferase activity but not the glucohy-
drolase or the auto-glucosylation activity of LtpM by about
5-fold. A half-maximal effect of PI3P was observed at the same
concentration range as the affinity of PI3P binding to LtpM.
This suggests that the binding of PI3P to LtpM not only directs
the localization of the effector in the cell but also opens or
unmasks a binding site for (protein) substrates. Recently, PIP or
membrane binding was also reported to control the activities of
SidC (41), RavZ (24), and RalF (47), indicating that this is a
widely adoptedmechanism and that there is evolutionary pres-
sure, which drives the fine-tuning of temporal and spatial con-
trol of effector activities. If the need to protect itself against
damage by uncontrolled modification of bacterial proteins
prior to effector translocation or limiting host cell damage
and detection by host defense surveillance systems are the
driving forces for this will be an intriguing question for
future investigation.
Our ectopic expression studies showed that LtpM is toxic for
yeast and to a lesser extent formammalian cells, suggesting that
LtpM is less active in mammalian cells or that it targets pro-
cesses, which are essential in yeast but not mammalian cells.
The Legionella glucosyltransferases Lgt1–3 are potent cytotox-
ins that inhibit protein synthesis (29, 38). We did not detect
inhibition of protein synthesis by LtpM. Instead, we found that
LtpM localizes to and reduces the mobility of Rab5- and Rab7-
containing early and late endosomes on microtubules in a
glucosyltransferase-dependent manner. As LtpM localizes to
the LCV during infection, these data point to a role in the
manipulation of the interaction of the LCVwith the endosomal
pathway and/or the movement of the LCV. Several effectors
have already been implicated in themanipulation of these path-
ways, for example LegK2 and VipD, which interfere with the
association and fusion of early endosomes with the LCV (48,
49); VipA, which derails organelle trafficking by modulating
actin polymerization (50); and LegG1,which altersmicrotubule
dynamics and LCV movement through the small GTPase Ran
(51). Our observation that the chromosomal deletion of ltpM
did not affect the proliferation of L. pneumophila in different
model hosts phenocopies findings for numerous otherDot/Icm
T4SS effector deletion mutants and is consistent with the
hypothesis that LtpM might target host cell processes that are
already heavily manipulated by additional effectors (13, 52).
Overall, LtpM resembles the L. pneumophila glycosyltrans-
ferase effector SetA in many aspects, including domain struc-
ture as well as localization and cytotoxicity upon ectopic
expression in eukaryotic cells (26). Sequence alignment and
structural homology modeling showed that LtpM shares sev-
eral conserved amino acids with other glycosyltransferases;
however, the absence of a conserved DxD motif, which is con-
sidered a hallmark of classical GT-A–type glycosyltransferases
and so far is found in all bacterial glycosyltransferase toxins,
including SetA, distinctly distinguishes LtpM.
The DxDmotif is involved inMn2, UDP, and glucose bind-
ing and typically is of critical importance for activity. In many
toxins, e.g. TcdB and PaTox, the second aspartate of the DxD
motif directly coordinates the divalent cation, whereas the first
coordinates via a water molecule and also interacts with the
hydroxyl groups of UDP-ribose and with glucose to position
UDP-glucose accurately in the catalytic cleft of the enzyme (33,
37, 53). This is supported by aromatic stacking between a tryp-
tophan residue and the uracil ring of the activated sugar.
Although Trp-13 of LtpM is placed to fulfill a similar function,
a DxN instead of the classical DxD motif is present. This DxN
motif is conserved in a large number of proteins containing
LtpM-like domains across various Legionella species. Our
experiments showed that despite this change, LtpM possesses
glucohydrolase and glucosyltransferase activity and, remark-
ably, that this activity does not require mono- or divalent
cations.
Fewmetal-independentGT-A–type glycosyltransferases, for
example the sialyltransferases from family GT42 (54) and
-1,6-GlcNAc transferase C2GnT-L (55), have been reported.
The metal-independent glycosyltransferase BoGT6 of the
intestinal commensal Bacteroides ovatus possesses an NxN
instead of aDxDmotif (56, 57). It has been proposed thatmetal-
independent glycosyltransferases use basic amino acids or the
hydroxyl group of tyrosines to stabilize the substituted phos-
phate leaving group (37). In LtpM, exchange of lysine 123 to
serine blocked the enzyme activity, indicating that this residue
might fulfill a similar function. Notably, conversion of the DxN
motif of LtpM into either a classical DxD or a BoGT6-like NxN
motif both rendered LtpM inactive, demonstrating that the full
DxN motif is essential for catalysis and suggesting that the
active site is optimized for this motif and not a degenerated
derivative of any previously described glycosyltransferase
domains. Futuremutational and structural studies of LtpMwill
expose its active-site geometry and catalytic mechanism.
Taken together, here we reveal that LtpM is the prototype of
a new, widely distributed family of Legionella Dot/Icm T4SS
glucosyltransferase effectors, which is localized and activated
by PI3P and exhibits a unique catalytic site structure, that,
unlike any other known glycosyltransferase toxin, functions
independently of metal ion cofactors.
Experimental procedures
Bacterial and yeast culture
Table 1 lists all bacterial and yeast strains used in this study.
Escherichia coli strains were grown using LB broth or agar, sup-
plemented with 30 g/ml chloramphenicol, 100 g/ml ampi-
cillin, or 50 g/ml kanamycin if the selection of plasmids was
required. L. pneumophila strain Paris (16) was cultured at 37 °C
on buffered charcoal yeast extract agar or in N-(2-acetamido)-
2-aminoethanesulfonic acid-buffered yeast extract (AYE)
liquid medium (58, 59). If required, Legionellamedia were sup-
plemented with 25 g/ml kanamycin and/or 6 g/ml chloram-
phenicol. All chemicals and reagents were acquired fromSigma
unless indicated otherwise.
S. cerevisiae MH272-3f or BY4741 was grown at 30 °C on
rich medium containing glucose (YPD: 1% yeast extract, 2%
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peptone, 2% glucose) or on minimal medium with the appro-
priate supplements (SD: 0.67% yeast nitrogen base without
amino acids (Difco), 2% glucose; SGal: 0.67% yeast nitrogen
base without amino acids, 2% galactose). The lithium acetate
protocolwas used to transformyeast (60). To assess the effect of
expression of different LtpM variants, serial dilutions of yeast
were spotted on SD and SGal medium. Growth was analyzed
after 3 days of incubation at 30 °C.
Cell culture
All human cell lines were purchased from the American
Type Culture Collection (ATCC) and maintained in a humidi-
fied atmosphere of 5%CO2 atminimal passages. A549 lung and
HeLa cervical epithelial cells were cultured in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum, GlutaMAXTM (Invitrogen), and nonessential
amino acids. Raw264.7 murine macrophage-like cells and
humanmonocyte-like THP-1 cells were grown in Roswell Park
Memorial Institute (RPMI) 1640 medium supplemented with
10% fetal bovine serum and GlutaMAXTM (Invitrogen). THP-1
cells were differentiated by addition of 50 ng/ml phorbol
12-myristate 13-acetate for 72 h.
D. discoideum strain AX2-214 was obtained from dictyBase
and grown static in HL5 liquid medium at 21–23 °C.
Molecular biology
Table 2 summarizes the plasmids and primers used and gen-
erated for this study. All enzymes for DNA manipulation were
obtained from New England Biolabs. Chromosomal DNA
of L. pneumophila strain Paris (genome accession number
NC_006368.1) was extracted using the Qiagen DNeasy blood
and tissue kit and used to amplify ltpM (lpp0356/lpp_RS01740,
protein accession number WP_011212979.1) by PCR. Point
mutations were introduced into pRK5Myc ltpM with the
QuikChange II site-directedmutagenesis kit (Agilent Technol-
ogies) and subcloned in other vectors as required. The sequence
identity of all generated constructs was validated by sequenc-
ing.L. pneumophilawas transformedwith the plasmids by elec-
troporation (61).
To create the L. pneumophila ltpM mutant, a kanamycin
resistance (kanR) cassette was amplified from pSB315 (62) by
PCR and inserted between bp 5 and 3 chromosomal flanking
sequences of the ltpM gene. The entire construct was amplified
by PCR and transformed into L. pneumophila by natural trans-
formation (63). Deletion of the ltpM gene in kanamycin-resist-
ant clones was confirmed by PCR and sequencing of the
genomic region.
Bioinformatics
The sequence of LtpM was analyzed for functional domains
and motifs using SMART (64), the eukaryotic linear motif
resource (65), and homologue proteins searched using NCBI
Blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Structural ho-
mology prediction was carried out using the Protein Homolo-
gy/analogY Recognition Engine Version 2.0 (Phyre2 (66)). Pro-
tein accession numbers for sequence alignments were as
follows: WP_010947098.1 (Lgt1/lpg1368); WP_010948548.1
(Lgt2/lpg2862); WP_061401042.1 (Lgt3/lpg1488); WP_
105161403.1 (TcdA); WP_003418170.1 (TcdB); WP_010947694.1
(SetA/lpg1978); WP_015834366.1 (PaToxG); WP_058442075.1
(Lbru_2087); WP_058503838.1 (Lnau_0778); WP_028372515.1
(Llan_2410); WP_058495616.1 (Ldro_1318); WP_058501861.1
(Lisr_1509); WP_045094905.1 (Lfa_0737); and WP_058388204.1
(Lche_3126).
Protein purification
E. coli (BL21CodonPlus) bacteriawere transformedwith the
desired plasmid and grown at 37 °C in LB broth supplemented
with the corresponding antibiotics (50 g/ml kanamycin and
50 g/ml chloramphenicol) until an absorbance of A600 0.8.
Protein expression was induced by 0.5 mM isopropyl -D-thio-
galactopyranoside (IPTG) (Roth, Karlsruhe, Germany), and
bacteria were grown for an additional 5 h at 23 °C. The bacterial
cells were harvested by centrifugation at 6000 rpm for 15 min
and were lysed in a lysis buffer containing 10 mM Hepes (pH
7.4), 150mMNaCl, 25mM imidazole, 1mM-mercaptoethanol,
30 g of DNase I, and protease inhibitor mixture cOmplete
(RocheApplied Science,Mannheim,Germany). Bacterial lysate
was extracted via high-pressure homogenization with an
M-110PMicrofluidizer (Microfluidics, Westwood, MA). Cel-
lular debris was removed via centrifugation (14,000 rpm for 1 h
at 4 °C) and filtration with sterile Filtropur S 0.45 filters from
Sarstedt (Nu¨mbrecht, Germany). Recombinant His6-tagged
LtpM protein (or mutants) was purified via fast protein liquid
chromatography with an A¨kta Purifier system and a nickel-
nitrilotriacetic acid column. Buffer A (10 mM Hepes (pH 7.4),
150 mM NaCl, 1 mM -mercaptoethanol) with an imidazole
gradient reaching from 25 to 500 mM was used for protein elu-
tion. Removal of imidazole was achieved by using Sephadex
Table 1
Bacterial and yeast strains used in the study
Strain Serogroup/ genotype Refs.
L. pneumophila
Paris O1; clinical isolate 16
Paris dotA dotA gene disrupted 73
Paris ltpM ltpM (lpp0356) gene disrupted This study
E. coli
Top10 Invitrogen
BL21-CodonPlus (DE3)-RIL E. coli B F ompT hsdS(rBmB) dcm Tetr gal (DE3) endA Hte
	argU ileY leuW Camr

Agilent Technologies
S. cerevisiae
MH272-3f ura3; leu2; his3; trp1; ade2 Stratagene (Agilent, Frankfurt, Germany)
BY4741 MATa; his31; leu20; met150; ura30 74
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Table 2
Plasmids and primers used and created in this study
RS means restriction site. References 28, 30, 38, 68, 69, 75–81 are cited in the table.
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Table 2—continued
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G-25 columns (GE Healthcare) according to the manufactu-
rer’s instructions.
Preparation of L. pneumophila for infection
L. pneumophila strains were prepared for infection as
described previously (67). Briefly, 3-ml AYE cultures contain-
ing 6 g/ml chloramphenicol were inoculated to an A600 of
0.2 and incubated at 37 °C shaking for 20 h before protein
expression was induced by adding 1 mM IPTG, if required.
21 h post-inoculation, the early stationary phase bacteria
were suspended in cell culture medium containing chloram-
phenicol (6 g/ml) and added to cells at a multiplicity of
infection (m.o.i.) of 0.5–100, as indicated for the specific
assays below. Infections were synchronized by centrifuga-
tion at 600  g for 5 min.
Translocation assay
Delivery of LtpM through the Dot/Icm T4SS into host cells
was measured using the -lactamase (TEM1) reporter as
described previously (68). L. pneumophila Paris carrying the
pXDC61 LtpM expression or control plasmids were induced
with 1 mM IPTG for 1 h and used to infect Raw264.7 cells at an
m.o.i. of 40. 1 h post-infection, the infected cells werewashed, and
20 l of fresh CCF2-AM -lactamase substrate (LiveBLAzerTM
FRET-B/G loading kit, Invitrogen) was added. 3 h post-infection,
excess CCF2-AM was removed by washing; the fluorescence
emission at 450 and 520 nm was recorded on a Fluostar Optima
plate reader, and the 450:520 nm emission ratio as an indicator of
protein translocation was calculated.
Microplate growth assays
Intracellular growth of L. pneumophila in differentiated
THP-1 cells was measured using a fluorescence microplate
reader assay as described previously (67). 8.5 104 THP-1 cells
were seeded per well of a black clear-bottom 96-well plate and
differentiated for 72 h. Themediumwas replacedwith 100l of
complete growthmediumwithout phenol red, but containing 6
g/ml chloramphenicol and 1 mM IPTG. Three wells per con-
dition were infected with the indicated L. pneumophila strains
carrying pXDC31 (GFP) or pXDC50 (mCherry) expression
plasmids (69) at an m.o.i. of 0.1–0.5. 1 h post-infection, the cell
supernatant was exchanged for medium containing 100 g/ml
gentamicin. After 1 h of incubation, the cells were washed three
times with PBS and then kept in supplemented growthmedium
without phenol red. Fluorescence was measured every 2 h over
a period of 72 h using a FLUOstar Optima plate reader (BMG
Labtech) equipped with atmospheric control unit (37 °C, 5%
CO2). To measure intracellular growth inD. discoideum, 8.5
104 amoeba per well were seeded in Low Fluorescence Axenic
Medium (LoFlo), and the assay was performed at room temper-
ature as described for the THP-1 cells.
Phospholipid overlay assay
Phospholipid overlay assays were performed with lipid strips
and PIP arrays purchased from Echelon Biosciences (Salt Lake
City, UT). Nitrocellulose membranes pre-spotted with differ-
ent phospholipids were blocked with 3% fat-free BSA in 50 mM
Tris-HCl (pH7.4), 150mMNaCl, 0.1%Tween 20 for 1 h at room
temperature and incubated with 100 nM recombinant LtpM
constructs in 2 ml of blocking buffer at 4 °C for 5 h. Binding of
the proteins to lipids was visualized by immunodetection with
primary anti-LtpM mouse polyclonal antibody and secondary
anti-mouse IgG antibody (Table 3).
Surface plasmon resonance spectroscopy
Interaction analysis of LtpM and PI3P was performed as
described previously (26) at 25 °C using a Biacore X100 biosen-
sor (GE Healthcare) equipped with an SA sensor chip (GE
Healthcare). Shortly thereafter, 200 nM biotin-PI3P (Echelon
Biosciences) in HBS-EP running buffer containing 10 mM
Hepes (pH 7.5), 150 mM NaCl, 3 mM EDTA, and 0.05% Tween
20 was injected across individual flow cells at a flow rate of 10
ml/min until response units reached 106.9. Fresh ligand sur-
faces were equilibrated by injecting three 60-s pulses of 1.0 M
NaCl and 25mMNaOH. Buffer for the dilution of recombinant
LtpM or BSA control was exchanged for the running buffer
containing 10 mM Hepes (pH 7.5) and 160 mM KCl by gel
filtration. 2-Fold serial dilutions of the analyte with concen-
trations ranging from 11 nM to 5.7 M were applied to the
chip for the contact time of 110 s with a flow rate of 50 l/s
with subsequent washing steps of 500 s. The sensor surfaces
was regenerated with a single pulse of 2 M guanidinium chlo-
ride for 60 s. Binding responses were referenced by subtract-
ing an average buffer response from at least two blank injec-
tions. Binding affinity was evaluated using the Biacore X100
evaluation software.
UDP-sugar hydrolase assay
UDP-sugar hydrolysis was measured as described (70).
Recombinant LtpM, LtpM mutants, SetA, or TcdB(1–546)
Table 3
Antibodies used in this study
Antibody (catalog no.) Source Supplier
EEA1 (ab50313) Rabbit Abcam (United Kingdom)
His-tag (2365) Rabbit New England Biolabs (Germany)
LtpM Mouse Y. Belyi, Gamaleya Research Center (Moscow, Russia)
Mouse IgG HRP-linked Rabbit New England Biolabs (Germany)
Rabbit IgG HRP-linked Goat Cell Signaling Technology
Rps9 Rabbit Eurogentec (Belgium), gift of S. Rospert (Freiburg University)
-Tubulin (DM1A) Mouse Santa Cruz Biotechnology (Germany)
Legionella (PA1-7227) Rabbit ThermoFisher Scientific (United Kingdom)
HA.11, clone 16B12 (MMs-101P-1000) Mouse Cambridge Bioscience (United Kingdom)
HA-tag (ab9110) Rabbit Abcam (United Kingdom)
Myc tag, clone 4A6 (05-724) Mouse Millipore (United Kingdom)
Alexa488-labeled/rhodamine RedX-labeled anti-rabbit or anti-mouse IgG Donkey Jackson ImmunoResearch (UK)
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were incubated with 10 M UDP-[14C]glucose in a buffer con-
taining 50 mM Hepes (pH 7.5), 3 mM MgCl2, 2 mM MnCl2, and
10 mM DTT in a total volume of 10 l at 30 °C (if other condi-
tions are not indicated). Buffer containing 50 mM Hepes (pH
7.5), 150 mM KCl, 3 mM MgCl2, 2 mM MnCl2, and 10 mM DTT
was used for TcdB(1–546). Samples of 0.8l were taken at each
time point and subjected to polyethyleneimine (PEI)-cellulose
TLC (Merck) with 0.2 mM LiCl as mobile phase to separate
products of UDP-glucose hydrolysis. The plates were dried and
analyzed by autoradiography using Typhoon FLA 7000 phos-
phorimager (GE Healthcare). Quantification was performed in
MultiGauge Version 3.0 software.
Glycosyltransferase assay
2 g of bovine serum albumin (BSA, New England Biolabs
(Frankfurt, Germany)), as an artificial substrate, was incubated
with recombinant LtpM or SetA and 10 M UDP-[14C]glucose
in a buffer containing 50mMHepes (pH7.5), 3mMMgCl2, 2mM
MnCl2, 10mMDTT, and 1MPI3P diC8 (Echelon Biosciences)
at 30 °C (if other conditions are not indicated). Total volume
was 20 l for the lysate glucosylation and 10 l for the glucosy-
lation of BSA. Labeled proteins were analyzed by SDS-PAGE
followed by phosphorimaging (Typhoon FLA 7000, GE
Healthcare, Freiburg, Germany).
Transient transfection
GeneJuice (Novagen) or Lipofectamine 2000 (Invitrogen)
reagents were used according to the manufacturer’s guide-
lines to transfect HeLa cells with eukaryotic expression
plasmids.
Cell viability assay
HeLa cells seeded in 24-well plates were transiently trans-
fected with 1 g of a desired plasmid (pmCherry-C1-LtpM,
pmCherry-C1-LtpM NxN, or empty pmCherry-C1). Trans-
fected cells were incubated for 18 h at 37 °C prior to live-cell
imaging. Time-lapse fluorescence and phase-contrast
images were collected every 10 min during the incubation of
the cells at 37 °C for 42 h in a Lionheart FX automatedmicro-
scope (BioTek). One time-lapse movie per well was
recorded. The images were analyzed for the number of
attached transfected cells at the selected time points using
Metamorph software.
Immunofluorescencemicroscopy
Cells on coverslips were fixed with 3.2% paraformaldehyde
(PFA), washed with D-PBS, incubated with 50 mM ammonium
chloride, washed, and permeabilized with 0.1% Triton X-100.
After blocking with PBS containing 2% (w/v) BSA and 2% (v/v)
natural donkey serum, samples were stained sequentially with
primary and secondary antibodies (Table 3) andmounted using
ProLong antifade reagent (Invitrogen). DNA was visualized
with Hoechst 33342 dye. Samples were analyzed using an Axio
Z1 Imager microscope (Fig. 1). Co-transfected cells were
imaged on a Zeiss Axiovert 200M inverted microscope (Carl
Zeiss, Jena, Germany). Typically 50–100 cells were accessed
per condition, and at least two independent biological repeats
were carried out per experimental series. Representative
images were deconvoluted and processed using AxioVision
software.
Cholera toxin B and transferrin trafficking assays
The transferrin recycling assay was carried out as described
previously (71). Briefly, HeLa cells were transfected with
either pmCherry, pmCherry–LtpM, or pmCherry–LtpM NxN
expression plasmids. After 21 h, medium was replaced with
serum-free DMEM containing 20 g/ml transferrin-647 (Tfn-
647, Invitrogen) and incubated at 37 °C for 1 h. Cells were
washed with PBS to remove residual Tfn-647, and the medium
was replaced with serum-free DMEM containing 100 g/ml
unlabeled holo-Tfn and incubated at 37 °C for 10, 30, or 60min.
At the indicated time points, cell were washed with ice-cold
PBS, trypsinized, fixed with 3.2% PFA, and then analyzed by
flow cytometry.
Cholera toxin B trafficking was analyzed in HeLa cells trans-
fected for 48 h with plasmid pmCherry-C1-LtpM, pmCherry-
C1-LtpM NxN, or pmCherry-C1 encoding for mCherry–
LtpM, mCherry–LtpM NxN, or mCherry, respectively.
Transfected cells were incubated with the minimal medium
for 30 min at 37 °C before the treatment with fluorescently
labeled subunit B of cholera toxin (CTxB–AlexaFluor488)
(Biotium (Biotrend), Cologne, Germany). CTxB–AlexaFluor488
was diluted with fresh ice-cold minimal medium to a final con-
centration of 1 g/ml. The cells were incubated with CTxB for
10 min on ice to allow binding to the cytoplasmic membrane.
After that, the medium was exchanged for fresh minimal
medium, and the cells were incubated at 37 °C for 0, 10, or 30
min. At the indicated time points, the cells were fixed with 4%
PFA and subjected to fluorescence microscopy analysis. To
quantify the trafficking of CTxB from the plasmamembrane to
intracellular compartments, at each timepoint the relative fluo-
rescence intensity ofCTxBper pixel, along a 150-pixel-long line
intersecting the plasmamembrane and entering about 100 pix-
els into the cell, was measured and plotted using Metamorph
software.
Vesicle speedmeasurement
HeLa cells plated on glass-bottom dishes were transiently
transfectedwith the desired plasmids. 6g of pmCherry–LtpM
or pmCherry–LtpM NxN plasmid and 3 g of marker-carried
plasmid were used for transfection. For live-cell imaging, cells
were incubated in a homebuilt microincubator that provided a
humidified atmosphere (6.5% CO2 and 9% O2) at 37 °C on a
Zeiss Axiovert 200M inverted microscope (Carl Zeiss, Jena,
Germany). Time-lapse images of moving vesicles were col-
lected for 3 min with 1-s intervals with a digital camera (Cool-
snap HQ, Roper Scientific, Tucson, AZ) driven by Visiview
4.0.0 (Visitron, Puchheim, Germany) imaging software. Images
with the resolution of 15.5 pixels per m were taken. Image
analysis and generation of video clips were performed using the
TrackMate plug-in (72) for ImageJ software. Vesicles on the
imageswere detected using the algorithmbased onLaplacian of
Gaussian filteringwith the estimated vesicle diameter of 0.7m
and the intensity threshold adjusted manually for each image
sequence.
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